{"rows":[{"id":5919,"title":"Psilocybin selectively suppresses novelty-induced grooming via 5-HT2B receptors: A microstructure analysis in Wistar rats.","authors":"Seillier A, El Dannan GI, Seillier L.","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2026-09-09","publication_year":2026,"doi":"10.1016/j.pnpbp.2026.111924","pubmed_id":"42716333","openalex_id":null,"source_url":"https://doi.org/10.1016/j.pnpbp.2026.111924","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-11 01:20:04","last_checked":"2026-09-16 01:20:16","bibtex":null,"source_record_id":"PMID:42716333","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.pnpbp.2026.111924","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42716333","source_url":"https://doi.org/10.1016/j.pnpbp.2026.111924","doi":"10.1016/j.pnpbp.2026.111924","pmid":"42716333","publication_date":"2026-09-09","importer_version":"2.1.3","text_redistributed":false}},{"id":5854,"title":"Effects of naturalistic psychedelic use on executive functioning: An online survey of lifetime history and recent use in university students.","authors":"Todesco S, Allan Z, Liu MYM, Schütz C.","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2026-08-11","publication_year":2026,"doi":"10.1016/j.pnpbp.2026.111888","pubmed_id":"42580581","openalex_id":null,"source_url":"https://doi.org/10.1016/j.pnpbp.2026.111888","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Observational Study","study_type":"Observational Study","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-13 01:20:05","last_checked":"2026-08-18 01:20:11","bibtex":null,"source_record_id":"PMID:42580581","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1016/j.pnpbp.2026.111888","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42580581","source_url":"https://doi.org/10.1016/j.pnpbp.2026.111888","doi":"10.1016/j.pnpbp.2026.111888","pmid":"42580581","publication_date":"2026-08-11","importer_version":"2.1.3","text_redistributed":false}},{"id":2523,"title":"Classic hallucinogens in the treatment of addictions.","authors":"Bogenschutz MP, Johnson MW","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2016-01-04","publication_year":2016,"doi":"10.1016/j.pnpbp.2015.03.002","pubmed_id":"25784600","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/25784600/","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Mystical Experience,Clinical Trial,Meta-Analysis,Review Article,Safety","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:25784600","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/25784600/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:25784600","source_url":"https://pubmed.ncbi.nlm.nih.gov/25784600/","doi":"10.1016/j.pnpbp.2015.03.002","pmid":"25784600","publication_date":"2016-01-04","importer_version":"2.1.3","text_redistributed":false}},{"id":2424,"title":"Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.","authors":"Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2018-02-02","publication_year":2018,"doi":"10.1016/j.pnpbp.2017.09.012","pubmed_id":"28947181","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/28947181/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:28947181","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/28947181/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:28947181","source_url":"https://pubmed.ncbi.nlm.nih.gov/28947181/","doi":"10.1016/j.pnpbp.2017.09.012","pmid":"28947181","publication_date":"2018-02-02","importer_version":"2.1.3","text_redistributed":false}},{"id":2343,"title":"Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.","authors":"Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2019-06-08","publication_year":2019,"doi":"10.1016/j.pnpbp.2019.01.002","pubmed_id":"30611836","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/30611836/","substance_tags":"psilocybin","topic_tags":"Depression,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:30611836","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/30611836/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:30611836","source_url":"https://pubmed.ncbi.nlm.nih.gov/30611836/","doi":"10.1016/j.pnpbp.2019.01.002","pmid":"30611836","publication_date":"2019-06-08","importer_version":"2.1.3","text_redistributed":false}},{"id":923,"title":"Classic psychedelics and the treatment for alcoholism.","authors":"Lodetti G, de Bitencourt RM, Rico EP","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2024-12-20","publication_year":2024,"doi":"10.1016/j.pnpbp.2024.111129","pubmed_id":"39181308","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39181308/","substance_tags":"psilocybin","topic_tags":"Addiction,Neuroplasticity,Aging,Clinical Trial,Review Article","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:05","bibtex":null,"source_record_id":"PMID:39181308","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39181308/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39181308","source_url":"https://pubmed.ncbi.nlm.nih.gov/39181308/","doi":"10.1016/j.pnpbp.2024.111129","pmid":"39181308","publication_date":"2024-12-20","importer_version":"2.1.3","text_redistributed":false}},{"id":867,"title":"The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.","authors":"Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-01-10","publication_year":2025,"doi":"10.1016/j.pnpbp.2024.111139","pubmed_id":"39251080","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39251080/","substance_tags":"psilocybin,psilocin","topic_tags":"Receptor Pharmacology,Biomarkers,Clinical Trial,Systematic Review,Review Article,Animal Study,In Vitro Study,Safety,Inflammation,Immune Function","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:39251080","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39251080/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39251080","source_url":"https://pubmed.ncbi.nlm.nih.gov/39251080/","doi":"10.1016/j.pnpbp.2024.111139","pmid":"39251080","publication_date":"2025-01-10","importer_version":"2.1.3","text_redistributed":false}},{"id":866,"title":"Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.","authors":"Ordovich-Clarkson RD, Jabbour M, Pelayo DA, Lara D, La Croix S, Mumman M, Stukas S, Anderson R, Meraz D, Bangura A, Anderson B, Bamrud L, Blake C","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-01-10","publication_year":2025,"doi":"10.1016/j.pnpbp.2024.111155","pubmed_id":"39357666","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39357666/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Mitochondrial Function,Oxidative Stress,Systematic Review,Review Article,Animal Study","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:39357666","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39357666/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39357666","source_url":"https://pubmed.ncbi.nlm.nih.gov/39357666/","doi":"10.1016/j.pnpbp.2024.111155","pmid":"39357666","publication_date":"2025-01-10","importer_version":"2.1.3","text_redistributed":false}},{"id":865,"title":"Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022).","authors":"Kopra EI, Penttinen J, Rucker JJ, Copeland CS","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-01-10","publication_year":2025,"doi":"10.1016/j.pnpbp.2024.111177","pubmed_id":"39437962","openalex_id":"https://openalex.org/W4403579240","source_url":"https://pubmed.ncbi.nlm.nih.gov/39437962/","substance_tags":"psilocybin","topic_tags":"Addiction,Safety,Toxicity","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:39437962","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39437962/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39437962","source_url":"https://pubmed.ncbi.nlm.nih.gov/39437962/","doi":"10.1016/j.pnpbp.2024.111177","pmid":"39437962","publication_date":"2025-01-10","importer_version":"2.1.3","text_redistributed":false}},{"id":864,"title":"Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats.","authors":"Wang Z, Robbins B, Zhuang R, Sandini T, van Bruggen R, Li XM, Zhang Y","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-01-10","publication_year":2025,"doi":"10.1016/j.pnpbp.2024.111243","pubmed_id":"39756636","openalex_id":"https://openalex.org/W4406062303","source_url":"https://pubmed.ncbi.nlm.nih.gov/39756636/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Biomarkers","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:39756636","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39756636/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39756636","source_url":"https://pubmed.ncbi.nlm.nih.gov/39756636/","doi":"10.1016/j.pnpbp.2024.111243","pmid":"39756636","publication_date":"2025-01-10","importer_version":"2.1.3","text_redistributed":false}},{"id":863,"title":"Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.","authors":"Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-01-10","publication_year":2025,"doi":"10.1016/j.pnpbp.2025.111249","pubmed_id":"39778644","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39778644/","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Toxicity","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:39778644","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39778644/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39778644","source_url":"https://pubmed.ncbi.nlm.nih.gov/39778644/","doi":"10.1016/j.pnpbp.2025.111249","pmid":"39778644","publication_date":"2025-01-10","importer_version":"2.1.3","text_redistributed":false}},{"id":862,"title":"Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.","authors":"Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-01-10","publication_year":2025,"doi":"10.1016/j.pnpbp.2025.111251","pubmed_id":"39788410","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39788410/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Systematic Review,Review Article,Animal Study,Healthy Volunteers,Treatment-Resistant Depression","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:04","bibtex":null,"source_record_id":"PMID:39788410","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39788410/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39788410","source_url":"https://pubmed.ncbi.nlm.nih.gov/39788410/","doi":"10.1016/j.pnpbp.2025.111251","pmid":"39788410","publication_date":"2025-01-10","importer_version":"2.1.3","text_redistributed":false}},{"id":775,"title":"Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.","authors":"de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-03-20","publication_year":2025,"doi":"10.1016/j.pnpbp.2025.111278","pubmed_id":"39892847","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39892847/","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Drug Interactions,Inflammation","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:01","bibtex":null,"source_record_id":"PMID:39892847","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39892847/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39892847","source_url":"https://pubmed.ncbi.nlm.nih.gov/39892847/","doi":"10.1016/j.pnpbp.2025.111278","pmid":"39892847","publication_date":"2025-03-20","importer_version":"2.1.3","text_redistributed":false}},{"id":774,"title":"Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.","authors":"Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-03-20","publication_year":2025,"doi":"10.1016/j.pnpbp.2025.111300","pubmed_id":"40010428","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40010428/","substance_tags":"psilocybin","topic_tags":"Addiction,Spirituality,Mystical Experience,Psychological Flexibility,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:01","bibtex":null,"source_record_id":"PMID:40010428","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40010428/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40010428","source_url":"https://pubmed.ncbi.nlm.nih.gov/40010428/","doi":"10.1016/j.pnpbp.2025.111300","pmid":"40010428","publication_date":"2025-03-20","importer_version":"2.1.3","text_redistributed":false}},{"id":750,"title":"Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.","authors":"Kurkova V, Winkler O, Greenshaw A, Jetly R, Swainson J, Lodewyk K, Saghafi P, Dennett E, Burback L","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-04-02","publication_year":2025,"doi":"10.1016/j.pnpbp.2025.111333","pubmed_id":"40113127","openalex_id":"https://openalex.org/W4408579473","source_url":"https://pubmed.ncbi.nlm.nih.gov/40113127/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Personality Change,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:00","bibtex":null,"source_record_id":"PMID:40113127","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40113127/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40113127","source_url":"https://pubmed.ncbi.nlm.nih.gov/40113127/","doi":"10.1016/j.pnpbp.2025.111333","pmid":"40113127","publication_date":"2025-04-02","importer_version":"2.1.3","text_redistributed":false}},{"id":749,"title":"The effect of low-dose psilocybin on brain neurotransmission and rat behavior.","authors":"Bysiek A, Wojtas A, Szpręgiel I, Wawrzczak-Bargieła A, Maćkowiak M, Gołembiowska K","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-04-02","publication_year":2025,"doi":"10.1016/j.pnpbp.2025.111347","pubmed_id":"40157708","openalex_id":"https://openalex.org/W4408958491","source_url":"https://pubmed.ncbi.nlm.nih.gov/40157708/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,OCD,Pharmacology,Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:00","bibtex":null,"source_record_id":"PMID:40157708","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40157708/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40157708","source_url":"https://pubmed.ncbi.nlm.nih.gov/40157708/","doi":"10.1016/j.pnpbp.2025.111347","pmid":"40157708","publication_date":"2025-04-02","importer_version":"2.1.3","text_redistributed":false}},{"id":748,"title":"Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.","authors":"Reiche S, Hirschfeld T, Gröticke AL, Traub M, Hafiz NJ, Haas R, Sedlaczek L, Ortlieb L, Leistenschneider G, Basedow LA, Lohse A, Bermpohl F, Riemer TG, Majić T","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-04-02","publication_year":2025,"doi":"10.1016/j.pnpbp.2025.111353","pubmed_id":"40174857","openalex_id":"https://openalex.org/W4409105951","source_url":"https://pubmed.ncbi.nlm.nih.gov/40174857/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:00","bibtex":null,"source_record_id":"PMID:40174857","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40174857/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40174857","source_url":"https://pubmed.ncbi.nlm.nih.gov/40174857/","doi":"10.1016/j.pnpbp.2025.111353","pmid":"40174857","publication_date":"2025-04-02","importer_version":"2.1.3","text_redistributed":false}},{"id":747,"title":"Psilocybin has a narrow therapeutic window as an antidepressant treatment.","authors":"Seillier L, Čechová B, Seillier A, Šlamberová R","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-04-02","publication_year":2025,"doi":"10.1016/j.pnpbp.2025.111368","pubmed_id":"40246053","openalex_id":"https://openalex.org/W4409449430","source_url":"https://pubmed.ncbi.nlm.nih.gov/40246053/","substance_tags":"psilocybin","topic_tags":"Adverse Events,Drug Interactions","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:00","bibtex":null,"source_record_id":"PMID:40246053","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40246053/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40246053","source_url":"https://pubmed.ncbi.nlm.nih.gov/40246053/","doi":"10.1016/j.pnpbp.2025.111368","pmid":"40246053","publication_date":"2025-04-02","importer_version":"2.1.3","text_redistributed":false}},{"id":607,"title":"Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats.","authors":"Danda H, Mazochová K, Šíchová K, Mazoch V, Olejníková-Ladislavová L, Syrová K, Jurásek B, Cihlářová P, Jurok R, Páleníček T, Kuchař M","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-07-13","publication_year":2025,"doi":"10.1016/j.pnpbp.2025.111439","pubmed_id":"40619050","openalex_id":"https://openalex.org/W4412043599","source_url":"https://pubmed.ncbi.nlm.nih.gov/40619050/","substance_tags":"psilocybin","topic_tags":"Anxiety,Pharmacology","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:40619050","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40619050/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40619050","source_url":"https://pubmed.ncbi.nlm.nih.gov/40619050/","doi":"10.1016/j.pnpbp.2025.111439","pmid":"40619050","publication_date":"2025-07-13","importer_version":"2.1.3","text_redistributed":false}},{"id":556,"title":"Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.","authors":"Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR","journal":"Progress in neuro-psychopharmacology & biological psychiatry","publication_date":"2025-08-30","publication_year":2025,"doi":"10.1016/j.pnpbp.2025.111448","pubmed_id":"40669813","openalex_id":"https://openalex.org/W4412433881","source_url":"https://pubmed.ncbi.nlm.nih.gov/40669813/","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Oxidative Stress,Review Article,Animal Study,Safety,Inflammation","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:57","bibtex":null,"source_record_id":"PMID:40669813","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40669813/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40669813","source_url":"https://pubmed.ncbi.nlm.nih.gov/40669813/","doi":"10.1016/j.pnpbp.2025.111448","pmid":"40669813","publication_date":"2025-08-30","importer_version":"2.1.3","text_redistributed":false}}],"total":28,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Progress in neuro-psychopharmacology & biological psychiatry","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}